Skip to main content
. Author manuscript; available in PMC: 2007 Mar 13.
Published in final edited form as: Alzheimer Dis Assoc Disord. 2006;20(1):6–15. doi: 10.1097/01.wad.0000191420.61260.a8

TABLE 3.

Sample Size Estimates Using FDG PET for Alzheimer Disease Trials5 Number of Alzheimer Disease Patients Per Treatment Group Needed to Detect an Effect With 80% Power in 1 Year

Treatment Effect
20% 30% 40% 50%
Frontal 85 38 22 14
Parietal 217 97 55 36
Temporal 266 119 68 44
Cingulate 343 153 87 57
Combined 62 28 16 10

P = 0.01 (two-tailed).

No adjustment for normal aging effects or subject attrition.

Adapted from Alexander et al, 2002.